Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
06.06. | J&J's Growth Strategy in Lung Cancer Borrows From Its Experience in Multiple Myeloma | ||
05.06. | INVEST Pitch Perfect Spotlight: How Pear Suite Makes Sure Community Health Workers Get Paid | ||
05.06. | Debunked Episode 16: Will Trump Administration's Drug Pricing Policies Lead to the End of PBMs? | ||
05.06. | The Behavioral Health AI Boom Is Real. So Are the Risks | ||
05.06. | A CIO's Guide to Scalable Patient Data Management | ||
05.06. | Healthcare's Provider Data Challenges | ||
05.06. | Lucet to Acquire Home Care Company Emcara Health | ||
04.06. | The GOP's Budget Plan Is a Crisis in the Making for Hospitals | ||
04.06. | Following Novo Nordisk, Eli Lilly Lands Partner for R&D of Longer-Acting Metabolic Meds | ||
04.06. | How Can RWD Transform the Patient Journey? | ||
04.06. | The Top 5 Home Care Franchise Opportunities in the U.S. | ||
04.06. | The Connected Patient Experience: 3 Tips to Empower Healthcare Delivery Through Innovation | ||
04.06. | The National Security Stakes of Pharmaceutical Tariffs | ||
04.06. | Navigating the AI in Healthcare Landscape and Its Future: A Preview of INVEST Digital Health 2025 | ||
04.06. | Kura Oncology Drug's Data at ASCO Support FDA Filing Now Under Priority Review for Leukemia | ||
03.06. | Pyx Health Acquires FarmboxRx With $47.5M Funding Boost | ||
03.06. | Weathering the Shifting Trial Landscape | ||
03.06. | The Age of Action: Seizing CMS's Call to Reimagine Medicare | ||
03.06. | BMS Buys Into BioNTech Bispecific Antibody, Putting Up $1.5B to Collaborate in Multiple Cancers | ||
03.06. | How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic | ||
02.06. | Wisp Unveils Diagnostics Arm | ||
02.06. | A Defining Moment for Employer Health Benefits: How the "One Big Beautiful Bill" Could Transform Healthcare for Employers | ||
02.06. | HIPAA's Blind Spot: It's Time to Address Client-Side Attacks | ||
02.06. | Allina Health Sees Early Success From Voice AI in Call Centers | ||
01.06. | At ASCO, Merck KGaA Shows How Its Drug Measures Up as Treatment for Rare Type of Tumor |